Carson Wealth (CWM LLC)
CRBP icon

Carson Wealth (CWM LLC)’s Corbus Pharmaceuticals CRBP Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$648 Sell
69
-80
-54% -$674 ﹤0.01% 5449
2025
Q4 		$1K Sell
149
-445
-75% -$5.49K ﹤0.01% 5186
2025
Q3 		$8K Sell
594
-1,005
-63% -$9.56K ﹤0.01% 4552
2025
Q2 		$11K Sell
1,599
-1,153
-42% -$8.38K ﹤0.01% 4228
2025
Q1 		$15K Buy
2,752
+2,698
+4,996% +$23.8K ﹤0.01% 3865
2024
Q4 		$1K Sell
54
-1,017
-95% -$17.1K ﹤0.01% 4678
2024
Q3 		$22K Buy
1,071
+1,048
+4,557% +$53.6K ﹤0.01% 3291
2024
Q2 		$1K Hold
23
– – ﹤0.01% 4344
2024
Q1 		$1K Buy
23
+20
+667% +$493 ﹤0.01% 4103
2023
Q4 		$0 Buy
+3
New +$16 ﹤0.01% 4186
2022
Q2 		– Sell
-3
Closed – – 3829
2022
Q1 		$0 Hold
3
– – ﹤0.01% 3563
2021
Q4 		$0 Buy
+3
New +$81 ﹤0.01% 3514

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Carson Wealth (CWM LLC)'s CRBP Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Corbus Pharmaceuticals (CRBP) stake by 54% in Q1 2026, selling an estimated $674 and leaving 69 shares worth $648. The position accounts for ﹤0.01% of the portfolio, ranked #5449.

Carson Wealth (CWM LLC) first reported a position in CRBP in Q4 2021 and has held it in 12 quarters since. The position peaked at $22K in Q3 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Carson Wealth (CWM LLC) held 69 shares of Corbus Pharmaceuticals worth $648 as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 80 Corbus Pharmaceuticals shares in Q1 2026, an estimated $674.
  • Corbus Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5449 holding.
  • Carson Wealth (CWM LLC) first reported a position in Corbus Pharmaceuticals in Q4 2021 and has held it in 12 quarters since.
  • Carson Wealth (CWM LLC)'s Corbus Pharmaceuticals position peaked at $22K in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.